Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXX0FK
|
||||
| Drug Name |
(S)-4-morpholino-4-oxo-2-phenyl-N-((S)-4-phenyl-1-(4-(trifluoromethoxy)phenylamino)butan-2-yl)butanamide
|
||||
| Synonyms |
CHEMBL241489
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C31H34F3N3O4
|
||||
| Canonical SMILES |
FC(F)(F)Oc1ccc(NC[C@H](CCc2ccccc2)NC(=O)[C@@H](CC(=O)N3CCOCC3)c4ccccc4)cc1
|
||||
| InChI |
InChI=1S/C31H34F3N3O4/c32-31(33,34)41-27-15-13-25(14-16-27)35-22-26(12-11-23-7-3-1-4-8-23)36-30(39)28(24-9-5-2-6-10-24)21-29(38)37-17-19-40-20-18-37/h1-10,13-16,26,28,35H,11-12,17-22H2,(H,36,39)/t26-,28-/m0/s1
|
||||
| InChIKey |
JTBLZWCKXWPBNR-XCZPVHLTSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.